The Walgreens Center for Health & Wellbeing Research
Welcome to the Walgreens Center for Health & Wellbeing Research.
Walgreens strives to impact the Triple Aim by improving the experience of care, improving the health of populations and reducing total health care costs. Our dedicated team works to demonstrate the impact and effectiveness of various pharmacy-led programs and services and how they can benefit patients, providers and payers.
Here you will find summaries, links and original documents related to our research in peer-reviewed publications and presentations at scientific conferences.
We look forward to your feedback and our efforts to improve health and wellness in America! If you have questions or suggestions, please contact us at email@example.com.
National Surveillance of COVID-19
Click here to view Walgreens COVID-19 Index
Interactive maps and graphs tracking COVID-19, including Omicron, and other emerging variants are updated daily.
Aegis Sciences Corporation and Walgreens COVID-19 diagnostic testing and whole genome sequencing contains ~15% of all COVID-19 results in the United States. The combination of diagnostic testing, genome sequencing, and patient information produces valuable epidemiologic insights.
Adherence to CFTRm therapies decreases with age but is particularly low among young adults:1
Download: Publicationopens PDF in new tab
1. Witt EA, Broadus AL, McElya B, Hira N. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Adherence Across Age Groups in Pharmacy Data. Presented at the North American Cystic Fibrosis Conference (NACFC) annual meeting, November 2-5, 2021, Online.
The data reported is from Walgreens Specialty Pharmacy patients with fills from 11/2013 to 6/2015.